CIN3

11 registered clinical trials studyying CIN3 — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa NCT05413798	UNC Lineberger Comprehensive Cancer Center	N/A
Completed	Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living NCT05413811	UNC Lineberger Comprehensive Cancer Center	N/A
Terminated	A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Ch NCT05584332	Shanghai Bovax Biotechnology Co., Ltd.	Phase 3
Recruiting	Regression of Cervical Precancerous Lesions and Associated Risk Factors NCT06147388	General University Hospital, Prague	—
Recruiting	Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine NCT05371353	Shanghai Bovax Biotechnology Co., Ltd.	—
Recruiting	Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years NCT05027776	Shanghai Bovax Biotechnology Co., Ltd.	Phase 3
Unknown	Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II NCT06015854	University Medical Center Groningen	Phase 2
Completed	Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT05372016	Shanghai Bovax Biotechnology Co., Ltd.	Phase 3
Completed	Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Fem NCT04425291	Shanghai Bovax Biotechnology Co., Ltd.	Phase 3
Recruiting	Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Female NCT04422366	Shanghai Bovax Biotechnology Co., Ltd.	Phase 3
Unknown	Cervical Cancer Screening With Human Papillomavirus Testing NCT01881659	International Agency for Research on Cancer	—